Introduction {#sec1}
============

Long term conditions (LTCs) are common and an increasing proportion of the burden of disease ([@bib22]; [@bib30]). People with LTCs have a higher prevalence of common mental health problems (CMHP), principally depression and anxiety ([@bib38]; [@bib39]; [@bib41]). People with chronic physical conditions and mental illness are more likely to use emergency services and have higher total, outpatient, and pharmaceutical expenditures than those without mental illness ([@bib41]).

A variety of case-management models are proposed for people with long term conditions ([@bib9]); and managing both mental and physical health is important ([@bib15]; [@bib21]). The principles of care described within the "Chronic care model" ([@bib3]) appear to be associated with improved clinical outcomes in both physical and mental health ([@bib4]; [@bib45]). In the UK the number of people with LTCs is increasing and these people make greater use of the health service ([@bib46]). Recent policy developments propose the greater use of mental health services in the long term care of people with LTCs ([@bib20]). However, the focus at health service level has been on improved case management by experienced nurses ("community matrons") and the use of risk scores to attempt to identify those at highest risk of readmission ([@bib14]).

Improving Access to Psychological Therapies (IAPT), principally the provision of brief interventions and access to cognitive behavioural therapy, has been provided by the NHS in England ([@bib6]); and we have shown that referral to these services is associated with a reduction in health care utilisation; people referred to IAPT are issued fewer sick certificates, have fewer admissions to hospital, bed-days, and emergency department attendances ([@bib24]).

We carried out this study to explore whether referral of people with LTCs to a psychological therapies service was associated with a change in health service utilisation or adherence to antidepressant therapy. The principal comparison in the paper is a controlled before and after comparison of those with LTCs exposed to IAPT compared with those with LTCs who are not.

Method {#sec2}
======

Overview {#sec2.1}
--------

We carried out anonymous linkage of general practice, hospital and psychological therapy service data. We report the prevalence of LTCs; and the proportion of people with CMHP who have an LTC.

Our cases are people exposed to IAPT (*n* = 1118) of whom 118 had an LTC and 932 did not; our controls were age, gender, practice matched with an approximate ratio of 6:1. Of the controls (*n* = 6711) 1155 had an LTC and 5556 did not ([Fig. 1](#fig1){ref-type="fig"}). The controls were identified from the total number of people with LTCs (*n* = 23,1310) or from the wider practice population without LTCs (*n* = 98,068).

We report the utilisation of health care resources by those with and without LTCs; and healthcare consumption before and after referral to IAPT. Finally, we make a controlled before and after comparison of the people with LTC and CMP (*n* = 118) and the controls with LTCs (*n* = 1115).

Sample {#sec2.2}
------

The study used linked primary care, psychological therapy and hospital datasets linked using our Secure and Private Record Linkage (SAPREL) method ([@bib25]). This novel method uses fuzzy-logic to link records without the researcher knowing the identity of the linked cases. Routinely collected primary care, psychological therapy clinic and hospital data were extracted for the registered population of 20 practices situated in two sites -- one in East London, the other in a northern city (*N* = 121,199 registered patients) as part of a National Institute for Health Research evaluation of IAPT demonstration sites ([@bib37]). We collected the following data from practices: basic demographic, mental health problems, sick-certificate issue, anti-depressant prescription and LTC data ([Fig. 2](#fig2){ref-type="fig"}). We extracted coded data for the study variables along with the related date, and where relevant the value field. The primary care data we extracted were coded using the Read Code system ([@bib23]); and extracted, aggregated and processed using our standard methods ([@bib31]).

Linked data collection {#sec2.3}
----------------------

The three sources of data were recorded differently: Primary care data were generally recorded by the general practitioners at the point of care; the IAPT data were a Department of Health defined minimum dataset completed by administrative staff or therapists; and Hospital Episode Statistics (HES) data were entered by medical record data entry staff after the episode was completed based on their interpretation of written clinicians\' notes. HES data comprises data about: in-patient (IP) data both number of episodes and length of stay -- commonly described as occupied bed day (OBD), out-patient (OP) and accident and emergency (A&E) attendances.

People with long term conditions (LTC) {#sec2.4}
--------------------------------------

This analysis focuses on the impact of IAPT on people with long term conditions (LTC). This study collected information on the following long-term conditions: Diabetes mellitus, Chronic Kidney Diseases (CKD), Heart failure, Ischaemic Heart Diseases, Hypertensive disease and Chronic Obstructive Pulmonary Diseases (COPD). A derived variable called "LTC" was defined as a diagnosis of at least one of these conditions. We compared the disease prevalence recorded with that reported in the Pay for Performance (P4P) quality indicators for the areas from where the sample was selected ([@bib35]).

Cases and controls {#sec2.5}
------------------

We defined our cases as the population referred to IAPT services (*n* = 1118, of whom 186 had LTCs) and the controls were people with LTC from within the group of people not referred to IAPT (*n* = 6711, of whom 1155 had LTCs). We used a computerised statistical programme to match controls to cases, following a standard process ([@bib33]). We listed the variables we wished to match on: age, gender and practice. Our goal was to get the best possible match with between four and eight controls per case. The steps of this process are as follows. Firstly, our cases (people referred to psychological therapies) are identified and we set the desired ratio and age matching range. We used 10-year age bands, and initially a ratio of eight cases to controls. We then run this and end up with a subset of matching people. We then sequentially add other variables seeing if we can achieve the maximum number of age-gender-practice matched controls. Six was the optimum selection, maximising the number of matches with the boundaries set; the nearness of the age-band match is shown in [Fig. 3](#fig3){ref-type="fig"}.

Outcome variables and comparisons made {#sec2.6}
--------------------------------------

We first explored the utilisation of health care resources by people with LTCs in the total practice population (*N* = 121,199). We then compared healthcare utilisation in the 6 months before and after referral to IAPT services, as well as the mean difference between the intervention group (people with LTCs referred to IATP, *n* = 186) and controls (*n* = 1155) in the 6 months before and after ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Analysis of the outcomes of the IAPT intervention was based on "intention to treat," that is, all those referred to IAPT whether or not they engaged with the service or completed their course of therapy ([@bib8]; [@bib16]).

Prescription issue as a proxy for adherence {#sec2.7}
-------------------------------------------

We used issue of prescriptions as a marker of adherence with antidepressant therapy. We counted the number of prescriptions issued in the last year, as a proxy measure of adherence. We accept that a proportion of people won\'t fill their prescription, though this has been estimated as \<5%. A much bigger problem with antidepressant consumption is that nearly a quarter of people only collect a single script and do not then attend for further follow-up ([@bib11]); we would expect that interventions that engaged people in their therapy might be associated with a higher mean number of antidepressant scripts.

Statistical methods {#sec2.8}
-------------------

We analysed the data in SPSS (PASW/IBM Statistics) version 18. We used descriptive data to compare the samples as well as inferential statistical procedures to compare differences in the outcomes. We used Pearson Chi-square to compare proportions, and we report odds ratios (OR) and 95% confidence intervals to report any association between the presence and absence of binary conditions (e.g. having an LTC and a CMHP). We used an independent samples *t*-test to compare differences in health care consumption.

We identified the 6711 controls from the practice population. We identified approximately 6 controls for each case. The date of the first therapeutic session was used to define the cut off between "before" and "after". If the date was missing we used the date of the initial assessment. We report the mean differences between groups to describe differences in the utilisation of health care services by the four groups:(1)The intervention group: Cases, people referred to IAPT (with CMHP) who have LTCs;(2)Cases, people referred to IAPT (with CMHP) without LTCs;(3)Controls, people with CMHP and LTCs; and(4)People with CMHP but without LTCs. We compared mean levels of health care utilisation between these groups ([Fig. 1](#fig1){ref-type="fig"}) before and after the intervention.

Ethical considerations {#sec2.9}
----------------------

An NHS national research ethics committee (reference No: 08/H0715/101) provided ethical review, and the research office of the local health care organisations involved provided local site approvals. In addition, specific approval was obtained from the Patient Information Advisory Group (PIAG) (now the National Information Governance Board and Section 158 exemption). The SAPREL process complied with the approved use and protection of patient information and was commended by PIAG as an example of best practice ([@bib24]).

Results {#sec3}
=======

Population {#sec3.1}
----------

he prevalence of LTC in the total practice population was 15.2% (23200/152302) and 18.8% (*n* = 23131/121,199) among people 16 years and over. The LTC cases comprised the following proportions of the practice population: Diabetes 5.7%; chronic kidney disease 4.6%; heart failure 0.8%; Hypertensive disease 14.5%; Chronic Obstructive Pulmonary Disease (COPD) 0.7%. These conditions were not mutually exclusive and co-morbidity was common. The prevalence of LTCs was similar but higher than that reported for P4P targets for the relevant NHS localities, [Table 1](#tbl1){ref-type="table"} ([@bib34]).

In the adult population (\>16 years, *N* = 121199) we found an association between CMPH and LTC, the OR of an association of was 1.21 (95% CI 1.15--1.26; *p* \< 0.001, [Table 2](#tbl2){ref-type="table"}). Each of the LTCs were associated with CMHP, (chi-square *p* \< 0.001), except heart failure where the proportion with CMHP was not significantly different and the 95% confidence intervals for the OR crossed parity (OR 1.09, 95% CI 1.07--1.27; Chi-square *p* = 0.43 n.s.). CMHP were almost twice as common in people with COPD; with one of the strongest associations (OR 1.75, 95% CI 1.46--2.11).

Utilisation of health resources by people with LTCs compared with those without {#sec3.2}
-------------------------------------------------------------------------------

Unsurprisingly, people with LTC were more likely to have higher health consumption that those without ([Table 3](#tbl3){ref-type="table"}). They received just over three times as many antidepressant prescriptions in the previous year, and had nearly three times as many sick notes. They also had nearly three times as many hospital admissions, and their total number of occupied bed days was roughly six times that of people without LTCs, suggesting a mean length of admission twice that of those without LTCs. People with LTCs had nearly 2.5 times as many outpatient attendances and 1.5 times as many visits to A&E.

Changes before and after referral {#sec3.3}
---------------------------------

People with LTC referred to IAPT were more likely to be prescribed antidepressant medications after referral (*p* \< 0.001), and less likely to attend A&E (*p* = 0.009; [Table 4](#tbl4){ref-type="table"}). Other differences between the groups before and after referral to IAPT were not significantly different.

Comparison of intervention and control groups for people with LTCs {#sec3.4}
------------------------------------------------------------------

Between the intervention (*n* = 186) and control group (*n* = 1155) with LTCs there were no significant differences in the proportion of the individual LTCs, or in their demographics including the ethnicity of the two groups ([Table 5](#tbl5){ref-type="table"}). The mean age in the intervention group was 53.0years (SD 10.99) and the same in the controls 52.6years (SD 11.24); psychological therapies were targeted at people of working age at the time of this study, [Fig. 3](#fig3){ref-type="fig"}. Most of the people with LTCs and CMHPs in the study population who were referred to IAPT were in the age bands between 45 and 60 years old, female, of white ethnicity, and less likely to be of Asian ethnicity. There was also no statistically significant difference in the prevalence of LTCs between the intervention and the control group: 16.6% (186/1118) compared with 17.2% (1155/6711), respectively (Pearson chi square *p* = 0.64 n.s, [Fig. 1](#fig1){ref-type="fig"}).

A six-month before and after comparison of people with LTC referred to IAPT revealed that they also received more prescriptions of anti-depressants (*p* \< 0.001) and had more out-patient appointments after referral (*p* = 0.003, [Table 6](#tbl6){ref-type="table"}). The number of admissions was unchanged, and although bed days fell from 1.33 to 0.36, this change was not statistically significant (*p* = 0.267). There was also a slight reduction in A&E attendance, also not statistically significant (*p* = 0.090).

Finally, we made a six-month before and after comparison with age, sex, practice matched controls of the intervention group with the control group with LTCs. Consistent with our earlier findings there was a statistically significant increase in prescription of antidepressants, over and above those prescribed to the control group (mean difference −0.94 vs. −0.32 respectively; *p* = 0.001). There was also a fall in A&E attendances, compared with an increase in the control group (0.11 vs. −0.10, respectively; *p* = 0.003). There was also an increase in out-patients attendances, a fall in bed days, and no change in admissions, but these differences were not significant ([Table 7](#tbl7){ref-type="table"}).

Discussion {#sec4}
==========

Principal findings {#sec4.1}
------------------

People with LTC had more admissions and much longer bed occupancy once admitted to hospital. With the exception of heart failure, people with CMHP are a little more likely to have co-morbid long term conditions (i.e. Diabetes, CKD, IHD, Hypertensive disease and COPD).

Referral of people with LTC and CMHP to an IAPT service was associated with increased antidepressant medication and less use of the emergency department than controls. There was a numeric decrease in the number of bed days and increase in out-patient use but these changes were not significant.

There appeared to be unrepresentativeness in terms of the gender and ethnicity of referrals to IAPT. More women and more people of white ethnicity were referred, and fewer of Asian ethnicity than would be expected if referral were evenly spread between ethnic groups.

Implications of the findings {#sec4.2}
----------------------------

LTCs are associated with CMHP, though we have no insight from these data as to the causal relationship.

Referral to IAPT seems to be appropriate for people with LTC and CMHP. It is plausible that the act of referral, which requires acknowledgement that there may be health benefit from treating a psychological component of their illness, may help provide insight and be therapeutic.

The over-representation of women, and people of with long term conditions and the ethnic disparity between groups warrants further exploration.

These results provide support for IAPT services. IAPT appears to add something to usual practice and may be more effective in dealing with the combination of LTC and CMHP by reducing their healthcare utilization. IAPT may have a role in helping to reduce attendances at A&E departments. It is possible that improving psychological health either directly improves physical health or patients ability to cope with symptoms from their LTC.

The disparity in referral between gender and ethnicity needs further exploration, but current service models may not be accessible to all ethnic groups and genders.

Comparison with the literature {#sec4.3}
------------------------------

Other studies have shown that people with LTC are known to use health services and resources to a greater extent than those without them, and comorbid CMHP further increases utilisation ([@bib41]).

We found people with COPD approximately twice as likely to have mental health problems as those without it; an increased prevalence of anxiety and depression in COPD patients has also been found in other studies ([@bib19]).

These results are consistent with a study which found that helping people recognize the link between their physical symptoms and their stress or emotions resulted in a drop in number of visits to emergency departments ([@bib1]). Also, antidepressant medications may have an additive effect further increasing the effect of psychological interventions and further reduce the use of services in patients with CMHP and LTCs ([@bib5]).

The findings about gender and ethnic disparities are compatible with other studies: Asian ethnicity is associated with a lower uptake of services ([@bib7]; [@bib18]); and females have higher consultation and prescribing rates in primary care and for depression ([@bib32]; [@bib40]).

Limitations of the method {#sec4.4}
-------------------------

A longer period of data observation would be able to confirm these outcomes more strongly. It is possible with long lead times between referral and review in outpatients and subsequent inpatients that the effect of the intervention (referral to IAPT) had not had sufficient chance to percolate through the system and have an impact. In theory the English NHS has a target that treatment should take place within 18 weeks of referral, approximately five months ([@bib12]). However, patients referred to IAPT are not treated instantly so any impact might not be picked up in a six month period of observation.

There are well known limitations to collecting and working with routinely collected data ([@bib27]) there are some possible limitations such as missing or incomplete data. We anticipated that the disease prevalence identified from the GP data would be higher because the P4P used a limited list of codes, defined within business rules ([@bib36]), whilst there were a much wider range of codes that might be used to identify people with each of these conditions. We had experience of many of the coding pitfalls in diabetes ([@bib26]), CKD ([@bib2]), heart failure ([@bib29]), and hypertension ([@bib44]). This was also not strictly a like-for-like comparison; the coding system used the term "Ischaemic Heart Disease (IHD)" whereas P4P used a narrower definition of "coronary heart disease (CHD); " the coding system also used the broader term "heart failure" whereas P4P was limited to left ventricular dysfunction. The only exception expected was COPD where the P4P prevalence could exceed that extracted from GP data. This was likely to be an artefact of the coding system which had similar rubrics for acute and chronic bronchitis (using the latter as a synonym for COPD) and where COPD (code H3), was a parent code of asthma, code H33 ([@bib10]).

Issue of prescriptions does not prove adherence ([@bib11]; [@bib17]). Whilst it would have been useful to have had a direct measure of adherence we cannot identify any reasons for a systematic bias between arms.

There are known weaknesses of the controlled before and after design ([@bib13]). Due to the non-randomised design it is difficult to draw causal inference; and there is potential for there to be unknown confounders a known problem with primary care databases ([@bib43]), even though we attempted to select a control group comparable to the intervention group. Other potential limitations include the absence of patient level details about the severity of the condition and variability in the quality of the IAPT service. Notwithstanding these limitations the study meets the criteria set by the Cochrane Effective Practice and Organisation of Care (EPOC) Review Group data collection checklist criteria for being included in EPOC reviews ([@bib28]).

Call for further research {#sec4.5}
-------------------------

The causal path is not explored from this analysis. Further research, possibly a cohort study, might explore whether LTC preceded CMHP, or do more people with CMHP go on to suffer from LTC.

We need to explore reasons for apparent bias in referral of more women than men -- seen in both people with and without LTCs. The data from this study would allow us to conduct a power calculation for a more definitive study, possibly a cluster randomised trial. Such an investigation could be used to explore any health economic benefit of the IAPT service.

Conclusion {#sec5}
==========

Referral to psychological therapies is associated with better adherence to antidepressant medicines and less A&E attendance, in people with LTCs and CMHPs. Larger studies are needed to explore the relationship with bed occupancy and attendance at out-patients as well as a longer period of observation to confirm these outcomes. The IAPT service reduces A&E attendances whilst simultaneously treating CMHP more effectively in people with long term physical illness.
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###### 

Prevalence of long term conditions identified in the study compared with best matching prevalence from P4P indicators.

                  Prevalence   
  --------------- ------------ -------
  Diabetes        5.7%         5.0%
  CKD             4.6%         2.9%
  Heart failure   0.8%         0.4%
  IHD/CHD         3.8%         3.2%
  Hypertension    14.5%        12.4%
  COPD            0.7%         1.6%

###### 

Recorded prevalence of long-term conditions, for population age 16 and over.

                   Common mental health problem (CMHP)                                                                           
  ---------------- ------------------------------------- ----------- ----------- ------------- ----------- -------------- ------ --------------
  **Population**   **\>16 yr**                           **12210**   **10.1%**   **108,989**   **89.9%**   121,199               
  Any LTC          Y                                     2665        21.8%       20,466        18.8%       23,131         1.21   *p* \< 0.001
  N                9545                                  78.2%       88,523      81.2%         98,068      (1.15--1.26)          
  Diabetes         Y                                     775         6.3%        6081          5.6%        6856           1.15   *p* \< 0.001
  N                11435                                 93.7%       102,908     94.4%         114,343     (1.01--1.24)          
  CKD              Y                                     644         5.3%        4974          4.6%        5618           1.16   *p* \< 0.001
  N                11566                                 94.7%       104,015     95.4%         115,581     (1.07--1.27)          
  CHF              Y                                     105         0.9%        860           0.8%        965            1.09   *p* = 0.403
  N                12105                                 99.1%       108,129     99.2%         120,234     (0,89--1.34)          
  IHD              Y                                     574         4.7%        4012          3.7%        4586           1.29   *p* \< 0.001
  N                11636                                 95.3%       104,977     96.3%         116,613     (1.18--1.41)          
  HT               Y                                     1901        15.6%       15,631        14.3%       17,532         1.10   *p* \< 0.001
  N                10309                                 84.4%       93,358      85.7%         103,667     (1.05--1.56)          
  COPD             Y                                     133         1.1%        680           0.6%        813            1.75   *p* \< 0.001
  N                12077                                 98.9%       108,309     99.4%         120,386     (1.46--2.11)          

Key: LTC = Long term conditions, CKD = Chronic kidney disease, CHF = Chronic Heart Failure, IHD = Ischaemic Heart Disease, HT = Hypertension, COPD = Chronic Obstructive Pulmonary Disease 95%, CI = 95% Confidence Intervals. Bold represents total population.

###### 

Utilisation of healthcare resources of people with long term conditions (LTC). A negative mean difference implies that something is more common in people with LTC.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of health consumption/Sick certification   LTC      *n*      Mean   Mean difference   SE difference   95% CI of difference   *t*-test sig. (2 tailed)
  ----------------------------------------------- -------- -------- ------ ----------------- --------------- ---------------------- --------------------------
  Psychotropic Medication\                        Y        23,131   2.7    −1.84             0.04            −1.92 to −1.76         *p* \< 0.001
  (Prescribed \<1 year)                                                                                                             

  N                                               98,068   0.87                                                                     

  Sick notes issued (\<1 year)                    Y        23,131   2.17   −1.39             0.03            −1.45 to −1.32         *p* \< 0.001

  N                                               98,068   0.78                                                                     

  Inpatient admissions                            Y        23,131   0.8    −0.52             0.02            −0.55 to −0.49         *p* \< 0.001

  N                                               98,068   0.28                                                                     

  Total days admitted (OBD)                       Y        23,131   3.58   −2.99             0.14            −3.26 to −2.72         *p* \< 0.001

  N                                               98,068   0.59                                                                     

  Outpatient attendances                          Y        23,131   3.9    −2.43             0.05            −2.52 to −2.33         *p* \< 0.001

  N                                               98,068   1.47                                                                     

  A&E attendances                                 Y        23,131   0.48   −0.17             0.01            −0.19 to −0.15         *p* \< 0.001

  N                                               98,068   0.3                                                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Utilisation of healthcare resources by people with LTC and CMHP 6 months before and after referral to IAPT. A negative mean difference implies greater consumption in a group, a positive mean difference a lower consumption.

                                                                 Group           Mean differences   Significance                                            
  -------------------------------------------------------------- --------------- ------------------ -------------- ------ ---------------- ---------------- -----------------------------
  Numbers of Anti-depressant Px -- prescribed in previous year   Case with LTC   186                −0.94          2.51   0.18             −1.3 to −0.58    ***p* \< 0.001\*\***
  Case without LTC                                               932             −0.27              2.03           0.07   −0.4 to −0.14                     
  Control with LTC                                               1155            −0.32              1.43           0.04   −0.4 to −0.24                     
  Control without LTC                                            5556            −0.11              1.03           0.01   −0.14 to −0.09                    
  **Total**                                                      7829            −0.18              1.31           0.01   −0.21 to −0.15                    
  Number of recent sick notes issued                             Case with LTC   186                0.01           1.08   0.08             −0.15 to 0.16    ***p* = 0.001\*\***
  Case without LTC                                               932             0.11               1.09           0.04   0.04 to 0.18                      
  Control with LTC                                               1155            0.04               0.86           0.03   −0.01 to 0.09                     
  Control without LTC                                            5556            0.00               0.75           0.01   −0.02 to 0.02                     
  **Total**                                                      7829            0.02               0.83           0.01   0.00 to 0.03                      
  Number of in-patient admissions                                Case with LTC   110                −0.02          0.54   0.05             −0.12 to 0.08    *p* = 0.901
  Case without LTC                                               500             0.02               0.75           0.03   −0.04 to 0.09                     
  Control with LTC                                               825             −0.02              1.50           0.04   −0.11 to 0.07                     
  Control without LTC                                            4701            −0.02              1.18           0.02   −0.05 to 0.01                     
  **Total**                                                      6136            −0.02              1.20           0.01   −0.05 to 0.01                     
  Total days admitted (Occupied bed days - OBD)                  Case with LTC   110                0.96           9.06   0.86             −0.75 to 2.68    *p* = 0.302
  Case without LTC                                               500             0.15               3.11           0.14   −0.12 to 0.43                     
  Control with LTC                                               825             −0.16              7.22           0.21   −0.58 to 0.25                     
  Control without LTC                                            4701            0.03               6.30           0.08   −0.13 to 0.2                      
  **Total**                                                      6136            0.02               6.34           0.07   −0.12 to 0.17                     
  Number out-patient attendances                                 Case with LTC   110                −0.5           1.71   0.16             −0.82 to −0.18   *p* = 0.636
  Case without LTC                                               500             −0.12              1.97           0.09   −0.3 to 0.05                      
  Control with LTC                                               825             −0.21              3.37           0.1    −0.41 to −0.02                    
  Control without LTC                                            4701            −0.20              2.70           0.04   −0.27 to −0.13                    
  **Total**                                                      6136            −0.2               2.76           0.03   −0.26 to -0.14                    
  Number of A&E attendances                                      Case with LTC   110                0.11           0.67   0.06             −0.02 to 0.24    ***p*** **=** **0.009\*\***
  Case without LTC                                               500             0.03               0.70           0.03   −0.03 to 0.09                     
  Control with LTC                                               825             −0.10              1.00           0.03   −0.16 to −0.05                    
  Control without LTC                                            4701            −0.08              0.98           0.01   −0.11 to −0.06                    
  **Total**                                                      6136            0.06               1.03           0.05   −0.1 to -0.05                     

Cases = people with CMHP referred to IAPT; Controls = people with CMHP not referred to IAPT. Bold represents statistical significance.

###### 

Demographic and clinical characteristics of people with LTC in the cases and control groups.

  Population         Cases LTC     Controls LTC   Population   Significance                
  ------------------ ------------- -------------- ------------ -------------- ----- ------ -------------
  Gender             *p* = 0.836                                                           
   Female            119           64             748          64.8           867   64.7   
   Male              67            36             407          35.2           474   35.3   
  Ethnicity                                                                                
   White             99            53.2           498          43.1           597   44.5   
   Black             20            10.8           138          11.9           158   11.8   
   Asian             14            7.5            129          11.2           143   10.7   
   Chinese & other   2             1.1            23           2              25    1.9    
   Mixed             2             1.1            10           0.9            12    0.9    
  LTCs                                                                                     
   Diabetes          55            29.6           370          32             425   31.7   *p* = 0.503
   CKD               26            14             175          15.2           201   15     *p* = 0.677
   Heart failure     5             2.7            38           3.3            43    3.2    *p* = 0.665
   IHD               25            13.4           186          16.1           211   15.7   *p* = 0.355
   Hypertension      133           71.5           799          69.2           932   69.5   *p* = 0.522
   COPD              2             1.1            28           2.4            30    2.2    *p* = 0.248

###### 

Utilisation of healthcare resources of people with LTC and CMHP (cases) before and after 6 months IAPT intervention.

                                       Referral to IAPT   *n*=   Mean   Mean difference   SE difference   95% CI of the difference   *t*-test sig. (2 tailed)
  ------------------------------------ ------------------ ------ ------ ----------------- --------------- -------------------------- --------------------------
  Numbers of Anti-depressant Px        Before             186    1.25   −0.94             0.18            −1.30 to −0.58             *p* \< 0.001
  After                                186                2.19                                                                       
  Number of recent sick notes issued   Before             186    0.41   0.01              0.08            −0.15 to 0.16              *p* = 0.946
  After                                186                0.40                                                                       
  Number of in-pt admissions           Before             110    0.25   −0.02             0.05            −0.12 to 0.08              *p* = 0.725
  After                                110                0.26                                                                       
  Total days admitted (OBD)            Before             110    1.33   0.96              0.86            −0.75 to 2.68              *p* = 0.267
  After                                110                0.36                                                                       
  Number out-pt attendances            Before             110    1.40   −0.50             0.16            −0.82 to −1.76             *p* = 0.003
  After                                110                1.90                                                                       
  Number of A&E attendances            Before             110    0.33   0.11              0.06            −0.02 to 0.24              *p* = 0.090
  After                                110                0.22                                                                       

###### 

Healthcare consumption in the six months before and after IAPT intervention - comparing cases and controls with LTC (controlled for age, gender and practice).

                                         People with LTC   *n*=    Mean changes   Mean difference between intervention and control   SE difference   95% CI of the difference   *t*-test sig. (2 tailed)
  -------------------------------------- ----------------- ------- -------------- -------------------------------------------------- --------------- -------------------------- --------------------------
  Numbers of antidepressant Px           Intervention      186     −0.94          −0.62                                              0.19            −0.99 to −0.25             *p* = 0.001
  Control                                1155              −0.32                                                                                                                
  Number of recent sick notes issued     Intervention      186     0.01           −0.03                                              0.08            −0.20 to 0.13              *p* = 0.649
  Control                                1155              0.04                                                                                                                 
  Number of admissions                   Intervention      110     −0.02          0.00                                               0.07            −0.13 to 0.13              *p* = 0.990
  Control                                1155              −0.02                                                                                                                
  Total bed-days admitted (OBD)          Intervention      110     0.96           1.13                                               0.89            −0.63 to 2.89              *p* = 0.207
  Control                                1155              −0.16                                                                                                                
  No of out-patients attendances (OPD)   Intervention      110     −0.50          −0.29                                              0.19            −0.66 to 0.09              *p* = 0.134
  Control                                1155              −0.21                                                                                                                
  Number of A&E attendances              Intervention      110     0.11           0.21                                               0.07            0.07--0.35                 *p* = 0.003
  Control                                1155              −0.10                                                                                                                
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